Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sträter

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cancer Research|February 11, 1998
Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosisU von Reyher, J Sträter, W Kittstein, et al.
Gut|April 16, 2005
Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual diseaseJ Sträter, U Hinz, C Hasel, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1994
PMA-activation of peripheral blood and tonsillar B lymphocytes induces large adhesive cells reminiscent of large extrafollicular (monocytoid) B cellsM Ruff, C Henne, T Barth, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1996
[Normal colon epithelium is highly sensitive to CD95-induced apoptosis. Indication for a role of cell death-induced CD95/CL95L systems under inflammatory inflammatory conditions?]J Sträter, H Walczak, I Wellisch, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2013
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survivalM Faehling, R Eckert, T Kamp, et al.
The American Journal of Pathology|January 23, 1999
CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95LJ Sträter, S M Mariani, H Walczak, et al.
Gastroenterology|July 1, 1997
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitisJ Sträter, I Wellisch, S Riedl, et al.
International Journal of Cancer|April 6, 2001
MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphomaP Möller, S Brüderlein, J Sträter, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancerM Givehchian, S Wörner, J Sträter, et al.
The Journal of Cell Biology|August 1, 1996
Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44A R Günthert, J Sträter, U von Reyher, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cancer Research|February 11, 1998
Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosisU von Reyher, J Sträter, W Kittstein, et al.
Gut|April 16, 2005
Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual diseaseJ Sträter, U Hinz, C Hasel, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1994
PMA-activation of peripheral blood and tonsillar B lymphocytes induces large adhesive cells reminiscent of large extrafollicular (monocytoid) B cellsM Ruff, C Henne, T Barth, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|January 1, 1996
[Normal colon epithelium is highly sensitive to CD95-induced apoptosis. Indication for a role of cell death-induced CD95/CL95L systems under inflammatory inflammatory conditions?]J Sträter, H Walczak, I Wellisch, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2013
EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survivalM Faehling, R Eckert, T Kamp, et al.
The American Journal of Pathology|January 23, 1999
CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95LJ Sträter, S M Mariani, H Walczak, et al.
Gastroenterology|July 1, 1997
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitisJ Sträter, I Wellisch, S Riedl, et al.
International Journal of Cancer|April 6, 2001
MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphomaP Möller, S Brüderlein, J Sträter, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancerM Givehchian, S Wörner, J Sträter, et al.
The Journal of Cell Biology|August 1, 1996
Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44A R Günthert, J Sträter, U von Reyher, et al.
Pageof 4